CVI-HBV-002 / CHA Vaccine Institute 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  CVI-HBV-002 / CHA Vaccine Institute
    Enrollment open, Phase classification, Trial completion date:  A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine (clinicaltrials.gov) -  Nov 14, 2023   
    P2,  N=153, Recruiting, 
    Trial primary completion date: Jul 2022 --> Dec 2023 Unknown status --> Recruiting | Phase classification: P2b --> P2 | Trial completion date: Dec 2021 --> Dec 2023